|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 852.60 DKK | +0.57% |
|
+2.75% | +2.08% |
| 06-10 | Self-driving truck firm Einride surges over 70% in Nasdaq debut | RE |
| 06-08 | Major European indices flat - Zealand Pharma plunges | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 66.63B | 70.26B | 73.58B | 75.01B | 89.1B | |||||
Total Revenues | 66.63B | 70.26B | 73.58B | 75.01B | 89.1B | |||||
Cost of Goods Sold, Total | 35.31B | 38.2B | 40.75B | 40.63B | 48.86B | |||||
Gross Profit | 31.33B | 32.07B | 32.83B | 34.38B | 40.24B | |||||
Selling General & Admin Expenses, Total | 20.93B | 21.6B | 22.46B | 23.66B | 28.08B | |||||
Other Operating Expenses | 49M | 58M | -17M | 66M | -415M | |||||
Other Operating Expenses, Total | 20.98B | 21.66B | 22.44B | 23.73B | 27.67B | |||||
Operating Income | 10.34B | 10.4B | 10.39B | 10.65B | 12.57B | |||||
Interest Expense, Total | -509M | -540M | -776M | -1.1B | -2.4B | |||||
Interest And Investment Income | 150M | 267M | 441M | 468M | 385M | |||||
Net Interest Expenses | -359M | -273M | -335M | -637M | -2.01B | |||||
Income (Loss) On Equity Invest. | 336M | 901M | 581M | 616M | 660M | |||||
Currency Exchange Gains (Loss) | -62M | -219M | -151M | 189M | -357M | |||||
Other Non Operating Income (Expenses) | 128M | -148M | -268M | -415M | 11M | |||||
EBT, Excl. Unusual Items | 10.39B | 10.67B | 10.21B | 10.41B | 10.87B | |||||
Restructuring Charges | -218M | -39M | -41M | -261M | -969M | |||||
Merger & Related Restructuring Charges | -48M | -92M | -117M | -413M | -680M | |||||
Impairment of Goodwill | - | -700M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | 5M | 13M | |||||
Gain (Loss) On Sale Of Assets | 93M | 79M | 47M | 44M | 84M | |||||
Asset Writedown | -864M | -64M | -310M | -284M | -687M | |||||
Other Unusual Items | 877M | 111M | 37M | 489M | 422M | |||||
EBT, Incl. Unusual Items | 10.23B | 9.96B | 9.83B | 9.99B | 9.05B | |||||
Income Tax Expense | 2.22B | 1.78B | 1.86B | 1.98B | 2.07B | |||||
Earnings From Continuing Operations | 8.01B | 8.18B | 7.97B | 8B | 6.98B | |||||
Earnings Of Discontinued Operations | - | -8.08B | -47.75B | 2.26B | - | |||||
Net Income to Company | 8.01B | 108M | -39.78B | 10.26B | 6.98B | |||||
Minority Interest | -1.16B | -1.17B | -1.01B | -1.15B | -1.02B | |||||
Net Income - (IS) | 6.85B | -1.06B | -40.79B | 9.12B | 5.96B | |||||
Net Income to Common Incl Extra Items | 6.85B | -1.06B | -40.79B | 9.12B | 5.96B | |||||
Net Income to Common Excl. Extra Items | 6.85B | 7.01B | 6.96B | 6.86B | 5.96B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 47.59 | -7.6 | -299.72 | 68.73 | 45.06 | |||||
Basic EPS - Continuing Operations | 47.59 | 50.14 | 51.14 | 51.71 | 45.06 | |||||
Basic Weighted Average Shares Outstanding | 144M | 140M | 136M | 133M | 132M | |||||
Net EPS - Diluted | 47.4 | -7.6 | -298.92 | 68.59 | 44.9 | |||||
Diluted EPS - Continuing Operations | 47.4 | 50 | 51 | 51.6 | 44.9 | |||||
Diluted Weighted Average Shares Outstanding | 144M | 140M | 136M | 133M | 133M | |||||
Normalized Basic EPS | 37.05 | 39.3 | 39.48 | 40.39 | 43.65 | |||||
Normalized Diluted EPS | 36.93 | 39.19 | 39.37 | 40.3 | 43.53 | |||||
Dividend Per Share | 24 | 27 | 27 | 27 | 29 | |||||
Payout Ratio | 46.55 | -318.81 | -9.06 | 39.5 | 59.93 | |||||
American Depositary Receipts Ratio (ADR) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Supplemental Items | ||||||||||
EBITDA | 14.36B | 13.96B | 13.92B | 14.39B | 17.47B | |||||
EBITA | 10.57B | 10.63B | 10.58B | 10.84B | 13.51B | |||||
EBIT | 10.34B | 10.4B | 10.39B | 10.65B | 12.57B | |||||
EBITDAR | 14.39B | 14.01B | 13.97B | 14.44B | 17.54B | |||||
Total Revenues (As Reported) | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 21.7 | 17.85 | 18.91 | 19.85 | 22.9 | |||||
Total Current Taxes | 2.42B | 2.2B | 2.01B | 2.33B | 2.73B | |||||
Total Deferred Taxes | -165M | -34M | -169M | -514M | -672M | |||||
Normalized Net Income | 5.33B | 5.5B | 5.37B | 5.36B | 5.77B | |||||
Interest Capitalized | 4M | 2M | 8M | 12M | 12M | |||||
Interest on Long-Term Debt | 17M | 25M | 40M | 69M | 104M | |||||
Non-Cash Pension Expense | 44M | 27M | 28M | 27M | -3M | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | 4.98B | 5.79B | 6.17B | 6.54B | 7.35B | |||||
Selling and Marketing Expenses | 16.73B | 17.34B | 18.36B | 19.24B | 23.13B | |||||
General and Administrative Expenses | 4.16B | 4.23B | 4.08B | 4.38B | 4.96B | |||||
Net Rental Expense, Total | 33M | 49M | 48M | 54M | 63M | |||||
Imputed Operating Lease Interest Expense | 4.58M | 7.38M | 8.89M | 12.49M | 22.34M | |||||
Imputed Operating Lease Depreciation | 28.42M | 41.62M | 39.11M | 41.51M | 40.66M | |||||
Stock-Based Comp., Other (Total) | 82M | 97M | 130M | 100M | 128M | |||||
Total Stock-Based Compensation | 82M | 97M | 130M | 100M | 128M |
- Stock Market
- Stocks
- CARL B Stock
- Financials Carlsberg A/S
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















